SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: M. Frank Greiffenstein who wrote (1585)3/26/1998 5:23:00 PM
From: Josef Svejk  Respond to of 5736
 
Thanks!



To: M. Frank Greiffenstein who wrote (1585)3/26/1998 5:41:00 PM
From: Clayleas  Respond to of 5736
 
<But rest assurred that Maisels is a very respected doctor in Southeastern Michigan>

...and everywhere else in the country.

I did some DD with a friend who is a neonatal specialist on staff at Barnes Hospital in St. Louis and her exact words were: "Is Jeff Maisels involved? If Jeff Maisels is involved, this is good!"

Jim



To: M. Frank Greiffenstein who wrote (1585)3/30/1998 12:29:00 PM
From: Eric Anderson  Respond to of 5736
 
I thought the clinical trials that CCSI conducted that were part of the FDA submittal and subsequent approval included such comparison tests with the heel prick. I think I read something back in 1996 that indicated that the Colormate system was tracking at almost a 100% level in comparison to the blood test - and that this "hit rate" was consistent across ethnic groups.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News